期刊文献+

MMP-1、PAR-1与子痫前期血管内皮损伤研究进展 被引量:3

THE RELATIONSHIP BETWEEN MMP-1,PAR-1 AND THEIR ROLES IN VASCULAR ENDOTHELIAL INJURY IN PREECLAMPSIA
下载PDF
导出
摘要 MMP-1是基质金属蛋白酶家族成员之一,具有降解细胞外基质中的Ⅰ和Ⅲ型胶原的作用。活化的MMP-1可介导血管壁胶原组织重构,引起管壁通透性增加,水肿和蛋白尿形成。蛋白酶活化受体-1(PAR-1)属于G蛋白偶联受体家族成员,激活后可介导内皮细胞释放ET-1增多并激活Rho激酶通路。子痫前期病人外周血MMP-1表达增高,上调的MMP-1可激活内皮细胞表面PAR-1导致ET-1释放增多,造成血管舒缩功能紊乱、血压增高。此外,MMP-1表达增高导致血管内皮对Ang II等因子的反应性上调亦在子痫前期的病理改变中具有重要作用。 Matrix metalloproteinase- 1 is a member of the group of the matrix metalloproteinases with the capacity to cleave the type I and the type Ⅲ collagen. The enhancement in collagenolytic activity suggested by the actived form of MMP- 1 during preeclampsia strongly implys the alteration of the collagen network in the blood vessel wall. The damage to this network might increase vascular permeability and then result in edema and proteinuria. PAR- 1 is a member of the group of the G protein- coupled receptors,which is known to mediate the release of endothelin 1( ET- 1) in endothelial cells and activate the Rho A kinase( ROCK) pathway. In preeclampsia,the plasma concentration of MMP- 1is significantly greater than that in normal pregnancy,and MMP- 1 is an activator of protease- activated receptor 1,Activation of endothelial PAR- 1 also results in the release of endothelin 1( ET- 1),which is a potent vasoconstrictor and plays an important role in the injury of vascular endothelial cells and hypertension. Additionally,the increased circulating levels of MMP- 1 in preeclampsia also has the ability to enhance vascular reactivity to vasoconstrictor hormones such as Ang II,these effects may play a vital role in the pathogenesis of preeclampsia.
作者 杨青 丁依玲
出处 《内蒙古医科大学学报》 2016年第2期143-146,共4页 Journal of Inner Mongolia Medical University
关键词 子痫前期 血管内皮损伤 基质金属蛋白酶-1 蛋白酶活化受体-1 preeclampsia vascular endothelial injury matrix metallo preteinase-1 protease-activated receptor-1
  • 相关文献

参考文献26

  • 1Shmueli A, Meiri H, Gonen R. Economic assessment of screening for pre- eclampsia [ J ]. Prenatal Diagnosis, 2012;32( 1 ) :29-38.
  • 2Estrada- gutierrez G, Cappello RE, Mishra N, et al. Increased expression of matrix metalloproteinase- l in systemic vessels of preeclamptic women:a critical mediator of vascular dysfunction [ J ]. The American Journal of Pathology,2011 ;178( 1 ) :451-460.
  • 3Cavusoglu E, Marmur JD, Hegde S, et al. Relation of baseline plasma romp- llevels to long- term all- cause mortality in patients with known or suspected coronary artery disease referred for coronary angiography[ J ]. Ather- osclerosis ,2015 ;239( 1 ) :268-275.
  • 4Jimbo K., Ohtsuka Y, Kojima Y, et al. Increased expression of cxcr 3 axis components and matrix metallo- proteinase in pediatric inflammatory bowel disease patients [ J ]. Pediatrics International, 2014 ; 56 ( 6 ) : 873 -883.
  • 5Mastenbroek TG, Feijge MA, Kremers RM, et al. Platelet- assoeiated matrix metalloproteinases regulate thrombus formation and exert local collagenolytie activity [ J ]. Arterioscler Thromb Vasc Biol ,2015 ;35(12) :2554-2561.
  • 6张壮,李宁毅,陈万涛,尚伟.口腔鳞癌中MMP-1、MMP-2、uPA的表达与肿瘤侵袭和转移的关系[J].实用口腔医学杂志,2006,22(4):469-473. 被引量:11
  • 7Mccawley L J, And matrisian LM. Matrix metalloproteinases: multifunctional contributors to tumor progression [ J ]. Mol Med Today, 2000 ; 6 (4) : 149-156.
  • 8Back M, Ketelhuth DF, Agewa11 S. Matrix metallopro- teinases in atherothrombosis [ J ]. Prog Cardiovasc Dis, 2010 ;52 (5) :410-428.
  • 9Guo H, Zucker S, Gordort MK, et al. Stimulation of matrix metalloproteinase production by recombinant extracelhalar matrix metalloproteinase inducer from transfected Chinese hamster ovary ceils. J Biol Chem, 1997 ;272( 1 ) :24-27.
  • 10Huang Y, Mironova M, Lopes- virella MF. Oxidized ldl stimulates matrix metalloproteinase- 1 expression in human vascular endothelial cells [ J ]. Arterioscler Thromb Vasc Biol, 1999 ;19( 11 ) :2640-2647.

二级参考文献29

  • 1于世凤 汪说之.口腔组织病理学(第5版)[M].北京:人民卫生出版社,2004.265-268.
  • 2Sidenius N, Blasi F. The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy. Cancer Metastasis Rev, 2003, 22 (2-3) :205
  • 3La Rocca G, Pucci-Minafra I, Marrazzo A,et al. Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera. Br J Cancer, 2004, 90(7) : 1414
  • 4Yoshizaki T, Sato H, Furukawa M. Recent advances in the regulation of matrix metalloproteinase 2 activation. From basic research to clinical implication (Review). Oncol Rep, 2002,9(3) :607
  • 5Yorioka CW, Coletta RD, Alves F, et al. Matrix metalloproteinase-2 and -9 activities correlate with the disease-free survival of oral squamous cell carcinoma patients. Int J Oncol,2002, 20(1) :189
  • 6Tsai CH, Hsieh YS, Yang SF, et al. Matrix metalloproteinase 2 and matrix metalloproteinase 9 expression in human oral squamous cell carcinoma and the effect of protein kinase C inhibitors: Preliminary observations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2003, 95(6) :710
  • 7Tanaka Y, Kobayashi H, Suzuki M, et al. Transforming growth factor-betal-dependent urokinase up-regulation and promotion of invasion are involved in Src-MAPK-dependent signaling in human ovarian cancer cells. J Biol Chem,2004, 279(10): 8567
  • 8Nelson AR, Fingleton B, Rothenberg ML,et al. Matrix metalloproteinases: Biologic activity and clinical implications. J Clin Oncol, 2000,18(5) :1135
  • 9Schmitt M, Wilhelm O, Janicke F, et al. Urokinase-type plasminogen activator (uPA) and its receptor (CD87) :A new target in tumor invasion and metastasis. J Obstet Gynaecol,1995, 21(2) :151
  • 10Sobin LH. TNM classification of malignanttumors/UICC. 6th ed. New York: Wily-Liss, 2002. 118 -126

共引文献25

同被引文献15

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部